• Something wrong with this record ?

Comparison of intraspinal and intrathecal implantation of induced pluripotent stem cell-derived neural precursors for the treatment of spinal cord injury in rats

T. Amemori, J. Ruzicka, N. Romanyuk, M. Jhanwar-Uniyal, E. Sykova, P. Jendelova,

. 2015 ; 6 (-) : 257. [pub] 20151222

Language English Country England, Great Britain

Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc16027811

BACKGROUND: Stem cell treatment provides a promising therapy for patients with spinal cord injury (SCI). However, the applied stem cells exert their effects in different manners that are dependent on the route used for administration. METHODS: In the present study, we administered neural precursors derived from induced pluripotent stem cells (iPS-NPs) either intraspinally into the lesion center or intrathecally into the subarachnoid space of rats with a balloon-induced spinal cord compression lesion. Functional locomotor performance, cell survival, astrogliosis, axonal sprouting and the expression of endogenous neurotrophic growth factors were evaluated using behavioral tests (BBB, flat beam test, rotarod, plantar test), morphometric analysis, immunohistochemistry and qPCR. RESULTS: Both treatments facilitated the functional locomotor recovery of rats with SCI. iPS-NPs injected intraspinally survived well for 2 months and were positive for MAP2, while cells grafted intrathecally were undetectable at the site of administration or in the spinal cord tissue. Intraspinal implantation increased gray and white matter sparing and axonal sprouting and reduced astrogliosis, while intrathecal application resulted only in an improvement of white matter sparing and an increase in axonal sprouting, in parallel with no positive effect on the expression of endogenous neurotrophic growth factor genes or glial scar reduction. CONCLUSIONS: Intrathecally grafted iPS-NPs had a moderate therapeutic benefit on SCI through a paracrine mechanism that does not require the cells to be present in the tissue; however, the extended survival of i.s. grafted cells in the spinal cord may promote long-term spinal cord tissue regeneration.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16027811
003      
CZ-PrNML
005      
20161031111151.0
007      
ta
008      
161005s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13287-015-0255-2 $2 doi
024    7_
$a 10.1186/s13287-015-0255-2 $2 doi
035    __
$a (PubMed)26696415
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Amemori, Takashi $u Department of Neuroscience, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20, Prague 4, Czech Republic. amemori@biomed.cas.cz. $7 gn_A_00005511
245    10
$a Comparison of intraspinal and intrathecal implantation of induced pluripotent stem cell-derived neural precursors for the treatment of spinal cord injury in rats / $c T. Amemori, J. Ruzicka, N. Romanyuk, M. Jhanwar-Uniyal, E. Sykova, P. Jendelova,
520    9_
$a BACKGROUND: Stem cell treatment provides a promising therapy for patients with spinal cord injury (SCI). However, the applied stem cells exert their effects in different manners that are dependent on the route used for administration. METHODS: In the present study, we administered neural precursors derived from induced pluripotent stem cells (iPS-NPs) either intraspinally into the lesion center or intrathecally into the subarachnoid space of rats with a balloon-induced spinal cord compression lesion. Functional locomotor performance, cell survival, astrogliosis, axonal sprouting and the expression of endogenous neurotrophic growth factors were evaluated using behavioral tests (BBB, flat beam test, rotarod, plantar test), morphometric analysis, immunohistochemistry and qPCR. RESULTS: Both treatments facilitated the functional locomotor recovery of rats with SCI. iPS-NPs injected intraspinally survived well for 2 months and were positive for MAP2, while cells grafted intrathecally were undetectable at the site of administration or in the spinal cord tissue. Intraspinal implantation increased gray and white matter sparing and axonal sprouting and reduced astrogliosis, while intrathecal application resulted only in an improvement of white matter sparing and an increase in axonal sprouting, in parallel with no positive effect on the expression of endogenous neurotrophic growth factor genes or glial scar reduction. CONCLUSIONS: Intrathecally grafted iPS-NPs had a moderate therapeutic benefit on SCI through a paracrine mechanism that does not require the cells to be present in the tissue; however, the extended survival of i.s. grafted cells in the spinal cord may promote long-term spinal cord tissue regeneration.
650    _2
$a zvířata $7 D000818
650    _2
$a buněčná diferenciace $7 D002454
650    _2
$a viabilita buněk $7 D002470
650    _2
$a indukované pluripotentní kmenové buňky $x cytologie $x transplantace $7 D057026
650    _2
$a spinální injekce $x metody $7 D007278
650    _2
$a lokomoce $7 D008124
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a regenerace nervu $7 D009416
650    _2
$a proteiny nervové tkáně $x genetika $x metabolismus $7 D009419
650    _2
$a nervové kmenové buňky $x cytologie $x transplantace $7 D058953
650    _2
$a parakrinní signalizace $7 D019899
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a poranění míchy $x patologie $x patofyziologie $x terapie $7 D013119
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ruzicka, Jiri $u Department of Neuroscience, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20, Prague 4, Czech Republic. j.ruzicka@biomed.cas.cz. Department of Neuroscience, 2nd Faculty of Medicine, Charles University, Plzenska 130/221, 150 00, Prague 5, Czech Republic. j.ruzicka@biomed.cas.cz.
700    1_
$a Romanyuk, Nataliya $u Department of Neuroscience, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20, Prague 4, Czech Republic. romanyuk@biomed.cas.cz.
700    1_
$a Jhanwar-Uniyal, Meena $u Department of Neurosurgery, New York Medical College, Valhalla, NY, 10595, USA. meena.jhanwar1@gmail.com.
700    1_
$a Sykova, Eva $u Department of Neuroscience, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20, Prague 4, Czech Republic. sykova@biomed.cas.cz. Department of Neuroscience, 2nd Faculty of Medicine, Charles University, Plzenska 130/221, 150 00, Prague 5, Czech Republic. sykova@biomed.cas.cz.
700    1_
$a Jendelova, Pavla $u Department of Neuroscience, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20, Prague 4, Czech Republic. jendel@biomed.cas.cz. Department of Neuroscience, 2nd Faculty of Medicine, Charles University, Plzenska 130/221, 150 00, Prague 5, Czech Republic. jendel@biomed.cas.cz.
773    0_
$w MED00188821 $t Stem cell research & therapy $x 1757-6512 $g Roč. 6, č. - (2015), s. 257
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26696415 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20161031111613 $b ABA008
999    __
$a ok $b bmc $g 1166125 $s 952441
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 6 $c - $d 257 $e 20151222 $i 1757-6512 $m Stem cell research & therapy $n Stem Cell Res Ther $x MED00188821
LZP    __
$a Pubmed-20161005

Find record

Citation metrics

Archiving options